American Medical Association, JAMA Internal Medicine, 11(182), p. 1223, 2022
DOI: 10.1001/jamainternmed.2022.4226
Full text: Unavailable
This cohort study used the Drugs@FDA database to identify new drugs approved by the US Food and Drug Administration (FDA) and assess fulfillment of postmarket commitments and requirements.